Sanara MedTech Inc. Common Stock
SMTIStock
$25.32−18.77%52W
Market Cap$224.75M
P/E—
Div yield—
Beta1.20
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-14.42%
Price vs S&P 500 (4W)7.55%
VGM Score51.29
Market Capitalization$224.75M
Earnings Surprise History
Q1 260.05est. -0.13
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
4.14
4.13
4.13
4.11
Industry Peers — Orthopedic & Prosthetic Devices(33)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
SMTISanara MedTech Inc. Common Stock | D | C | C | $25.32 |
| ISRGIntuitive Surgical Inc. | D | B | D | $402.33 |
| EWEdwards Lifesciences Corp | D | C | B | $87.84 |
| STESTERIS plc | B | B | C | $221.13 |
| ZBHZimmer Biomet Holdings, Inc. | B | C | C | $93.75 |
| ALGNAlign Technology Inc | C | C | C | $178.41 |
| SNNSmith & Nephew plc | B | C | C | $31.41 |
| MSAMine Safety Incorporated | C | C | C | $173.39 |
| ESTAEstablishment Labs Holdings Inc. | F | A | A | $92.30 |
| ENOVEnovis Corporation | B | D | C | $28.07 |
| CDRECadre Holdings, Inc. | B | C | D | $30.18 |
About
Sanara MedTech develops medical technologies for wound and skincare management across acute and post-acute care settings. Its portfolio includes CellerateRX for surgical wounds and BIAKOS for chronic wound care, addressing a substantial market opportunity. The company's comprehensive product offerings target improved clinical outcomes and reduced healthcare costs.